Nick Sundich
MTM Critical Metals (ASX: MTM): A company with technology poised to revolutionise metal refinery as we know it
Metal recovery may never be the same again if MTM Critical Metals (ASX:MTM) has its way. Metal refinery will become…
Imugene (ASX:IMU): This exciting biotech has multiple clinical trial readouts expected in the next 12 months
Imugene (ASX:IMU) is still valued at over $400m, in spite of being valued at over $2bn back in 2021 and…
Here are 5 ASX stocks with obscure HQ locations
Here are 5 ASX stocks with obscure HQ locations Maas Group (ASX:MGH) – Dubbo, NSW This company is based…
Mastercard or Visa? Which of these 2 stocks appears more attractive?
Should you invest in Mastercard or Visa? It is a difficult question for investors to answer. These payment giants hold…
Do oil and gas stocks have a future? Not if the IEA forecasts for 2050 oil demand are correct
Do oil and gas stocks have a future…at all? And if they do, what does it look like? Evidently, it…
Betting stocks: How do they make their money? Here are the top 4 ways
The revenue model of Betting stocks is different to any other industry and can confuse even the most seasoned analysts.…
CDIs (Chess Depository Interests): Why are some ASX companies listed in this way?
Some ASX companies have their shares listed as CDIs, or ‘Chess Depository Interests’. This is particularly true with American companies…
Here are 4 useful retirement investment portfolio diversification tips
Retirement investment portfolio diversification is an essential strategy for any investor seeking to reduce risk and maximise returns. But how can…
Osmond Resources (ASX:OSM): The stars are lining up for this company with its Orion EU Critical Minerals Project
On 6 September 2024 the stock of the mineral explorer Osmond Resources (ASX: OSM) started coming back to life. Before…
AMP (ASX:AMP): It is up 50% since November 2023! Is a better future ahead?
One time wealth management giant AMP (ASX: AMP) has endured a massive fall from grace over the years. There is…
Here are 5 companies that use an October to September financial year, and are reporting FY24 results soon
If you thought reporting season was done and dusted for all companies, you’d be wrong – because some companies use…
Island Pharmaceuticals (ASX:ILA): One of the rare ASX biotechs fighting mosquito diseases – and it’s in Phase 2
Island Pharmaceuticals (ASX:ILA) is one of the few (if not the only) ASX-listed Biotechs that is focused on mosquito diseases,…
Here’s why you’ll see more ASX biotechs focus on Asia in the years ahead!
Investors should expect to see more ASX biotechs focus on Asia in the years ahead. And there are good reasons…
Blinklab (ASX:BB1): Is this exciting company the next ResApp?
Blinklab (ASX:BB1), the conclusion to the response to a question of how you could help children with autism – a…
Here are 5 useful ways other than NPAT to measure a company’s performance
How can you judge measure a company’s performance other than through NPAT? NPAT (Net Profit After Tax) is a useful guide…
So your company announced a non-binding MOU: Is it a genuine deal or desperate puffery?
When you’re invested in a microcap stock, you might hear it has signed a ‘non-binding MOU’ (short for Memorandum of…
How can you build a stock portfolio that delivers good returns? Here are 4 necessary steps
How can you build a stock portfolio that generates good returns and grows your wealth? It’s not easy but it…
Vinyl Group (ASX:VNL) is finding its groove in 2025
Vinyl Group (ASX: VNL) is the only ASX-listed company offering exposure to the music technology and media industries. It has…
Currency hedging: Here’s how it works and why it’s so important to so many companies and investors
You’ll commonly hear the term ‘currency hedging’. It is undertaken by many companies as part of the ordinary course of…
Here are 5 ASX data centre stocks other than NextDC
If you thought the list of ASX data centre stocks only comprised of NextDC (ASX:NXT), you’d be wrong. NextDC’s success…
Santos (ASX:STO): Is this the ASX’s best positioned oil and gas stock?
Santos (ASX:STO) looks to the best of the Big 3 ASX oil and gas stocks (the other 2 being Woodside…
Want to find good software stocks? Here are 4 important traits you need to look for
Software stocks have provided amongst the highest returns of any ASX sector. There have been plenty of success stories in…
Baby Bunting (ASX:BBN): FY25 will be better, but will investors give it the recognition?
Baby Bunting (ASX:BBN) is the poster child for what’s been happening retailers in a cost of living crisis…on steroids. This…
Cobalt: Why is it so important and what are its prospects over the next 5 years?
Of all the resources used in electric vehicles, cobalt is the most under-rated. Compared to other battery minerals, it is…
The Webjet demerger is complete, but which side of the demerger will win?
Earlier this week, the Webjet demerger was complete. The entity known as Webjet (ASX:WEB) still owns the consumer facing businesses…
How can you estimate future dividends? Here are 3 useful ways to prevent a long, nervous wait
How can you estimate future dividends? One of the key reasons people buy stocks is for dividends, especially in Australia where…
Here’s why you should attend Semiconductor Australia 2024 – Australia’s premier semiconductor industry event
In 3 weeks time, on 24 October, Semiconductor Australia 2024 will take place in Sydney. Hosted by BluGlass, Sharecafe and…
There’s a Biotech Patent Cliff coming! Here’s why it could spell doom for large caps, but a generational opportunity for small caps
There’s a Biotech Patent Cliff coming over the next decade! Investors aren’t giving this much attention, but we think they…
Here’s why ASX vanadium stocks are worth a closer look & our 3 favourite
ASX vanadium stocks may not appear the sexiest of battery metal stocks. Investors in battery metals stocks may be more…
Build to Rent Apartment Construction is on the rise! Here’s how to access this sector on the ASX
For years, investors have heard hype about the Build to Rent, but the hype has not matched reality…until now. …
Woodside Energy (ASX:WDS): Oil and gas isn’t dead just yet, but where does this energy giant’s future lie
Woodside Energy (ASX:WDS) is the ASX’s largest energy company, capped at nearly $50bn. A traditional oil and gas giant, a…
Here’s what you need to know about AML and CTF laws if you invest in The Big 4 Banks
AML and CTF laws are particularly relevant to a handful of large companies, particularly the Big Four Banks as well…
Life360 (ASX:360): What other company lets you know where your loved ones are?
Life360 (ASX:360) is this week’s stock of the week. It is both an international and domestic stock, because the Silicon…
Universal Store (ASX:UNI): Positioned to benefit in FY25 as Millennials and Gen Z spend with a vengence
Let’s take a look at Universal Store (ASX:UNI), a chain of casual fashion stores aimed at Millennial and Gen Z…
Here’s how to buy US shares from Australia and 5 key factors for investors to consider
Many investors want to know how to buy US shares from Australia and we’ll seek to answer that question in…
Looking for EV stocks other than Tesla? Here are 5 of the hottest ones
Tesla (NDQ:TSLA) has undoubtedly been the pioneer among EV stocks, but it’s not the only one anymore. There are other pioneer…
How to achieve the Great Australian Dream through stock investing
Are you asking yourself how to achieve the Great Australian Dream? Some say it is no longer a thing given…
Should I buy Tesla shares from Australia? Only if you’re going to hold for 5-10 years
Should I buy Tesla shares from Australia? The world’s largest and most famous electric vehicle maker may seem like a…
Here is how a franchising works and 5 stocks with this business model
Should you invest in business with a franchising model? There’s plenty of companies out there, and you may be investing…
2025 ASX IPOs: Here are 4 important floats to watch out for
The class of 2024 ASX IPOs isn’t complete just yet but attention should be turned to the class of 2025…
Neuren Pharmaceuticals (ASX:NEU): Another exciting chapter is yet to come with NNZ-2591
Neuren Pharmaceuticals (ASX:NEU) is an ASX biotech company that has had a stellar past few years, but it is now…
Where to next for Solomon Lew and Premier Investments? Does it still have the upper hand on Myer?
Premier Investments (ASX:PMV) is one of those companies synonymous with its boss and this company’s leader is Solomon Lew. Premier…
How do Insurance stocks make money? And are they a safe investment?
Insurance stocks have among the most peculiar business models of all listed companies. Consumers may only see a company that…
Australia’s Future Fund: What does Australia’s $290bn sovereign wealth fund invest in?
Let’s take a look at Australia’s Future Fund. Specifically how it grew to A$290bn in Funds Under Management (FUM) and…
Axel REE (ASX: AXL) gets ready for the big time
The equity market hasn’t been kind to Axel REE (ASX: AXL), which has three high quality rare earths projects in…
Medibank Private shares have recovered the losses after the cyber breach 2 years ago, but what’s next?
Medibank Private (ASX:MPL) shares took a big hit nearly 2 years ago due to the infamous cyber breach. Investors who…
What is a contrarian investor, who are some of the most famous ones and can I make money if I adopt this strategy?
What is a contrarian investor? Are they nobodies on the fringe of the market? Or are they the prophets you…
Here are 6 of the longest serving ASX CEOs
One of biggest shocks among large caps this year was news that one the longest serving ASX CEOs, NIB boss…
Here are the 2 most important stock market taxes that investors need to be aware on
As one of two certainties in life, investors need to be aware of stock market taxes. Investors may be liable…
Bubs Australia (ASX:BUB): One of the few infant formula stocks building a post-China future
Bubs Australia (ASX:BUB) just might have a future beyond China. After the pandemic shut down the infant formula trade, companies…
5 ASX stocks that Australian Ethical bought or sold recently
We often like to look at shares that well known ASX fund managers are trading, and today we’re looking at…
Should you invest in aged care stocks? Here are 4 reasons to consider them, and 4 reasons to avoid them
Should you invest in aged care stocks? There are plenty of things to like about this sector, including government funding,…
IGO shares shed 66% in 14 months – will they bounce back or are you catching a falling knife?
For several years IGO shares reaped the benefits of growing demand for battery metals and the fact it was well…
Intelligent Monitoring Group (ASX:IMB): It is Australasia’s largest independent security monitoring provider and is up >200% in 12 months!
Intelligent Monitoring Group (ASX:IMB) has had a terrific FY24. It made >$40m EBITDA, went from being the 3rd largest company…
Here’s what you need to know about the TGA Special Access Scheme and why its a game changer for ASX biotechs
For ASX biotechs wishing to commercialise drugs in Australia, the Therapeutic Goods Administration (TGA) Special Access Scheme is the next best…
How will the stock market do tomorrow? Here’s how Stock Futures can be a reliable indicator to that question
How will the stock market do tomorrow? All investors wonder this question, yet the only way they know for sure…
After a 60% plunge in 4 months, are Mineral Resources (ASX:MIN) and its lithium peers on the rebound?
Mineral Resources (ASX:MIN) avoided much of the lithium price rout, until a few months ago. For investors, the company’s diversification…
The 2024 Pitt Street Research Life Sciences Conference is coming up! And you’re invited!
The Pitt Street Research Life Sciences Conference is happening on September 19, 2024! The Life Sciences sector in Australia and…
Gearing: What is it and how can companies exploit it to their advantage?
You may hear a company talk about its gearing. Generally only when it has a low level of gearing, of…
Immutep (ASX:IMM): Set to commercialise its lung cancer treatment by 2027
Developing a cancer drug is a long journey, but Immutep (ASX:IMM) is more towards the end than the start. A…
Private equity: Here’s what it is, and how the sector can be a blessing and a curse to retail investors
You may have heard of the term ‘Private Equity’ (PE) before. You may have seen a company been taken over…
Adobe (NDQ:ADBE): The 42-year old company behind PhotoShop and PDFs may have an even richer future ahead, driven by AI
Outside the so-called Magnificant Seven stocks, Adobe (NDQ:ADBE) is one of the most well-known by investors, as well as the…
Here are 6 stocks that got promoted in the ASX quarterly rebalance, and 6 that got demoted
On Monday September 23, the ASX quarterly rebalance will be effective. Stocks will be promoted into new indices, while others…
Private Credit: What is it and why has this US$1tn market become such a popular investment option?
Private credit is a US$1 trillion (A$1.49tn) market and $200bn in Australia alone. It is clearly worth knowing about and…
Challenger (ASX:CGF): Are investors panicking too much?
Shareholders in Challenger (ASX:CGF) didn’t take the news of Apollo’s sell down well. Apollo, a global fund manager, sold half…
Invion (ASX:IVX): Using Photodynamic Therapy to fight cancer
Unless you’re a professional dermatologist, you may not have ever heard of Photodynamic Therapy, let alone thought of it as…
Bio Gene Technology (ASX:BGT): Commercialising a new class of insecticides
Bio Gene Technology (ASX:BGT) ASX-listed AgTech company developing two compounds – Flavocide™ and Qcide™ – as insecticides. Investors may hear…
Paradigm Biopharmaceuticals (ASX:PAR): An osteoarthritis solution that could hit the market within 3 years
If you thought the were plenty of treatments for osteoarthritis already, Paradigm Biopharmaceuticals (ASX:PAR) is a company that has something…
Cann Group (ASX:CAN): Successfully producing GMP medicinal cannabis since 2017
Cann Group (ASX:CAN) is the first company in Australia that was issued a medicinal cannabis license, granted by the Australian…
CET1 ratio: If you invest in ASX bank stocks, here’s why it is an important metric to know
In this article we look at the Common Equity Tier 1 (CET1) ratio – what it is and why it…
Star Entertainment Group (ASX:SGR): Where to now in a post-COVID world? Can it avoid a looming cash crunch?
In a July interview with the AFR, Star Entertainment Group boss Steve McCann admitted that his company’s pre-pandemic glory days…
Prescient Therapeutics (ASX:PTX): About to take the plunge into a Phase 2 trial against T-Cell Lymphoma
There’s plenty of ASX oncology biotechs conducting clinical trials, but Prescient Therapeutics (ASX:PTX) is one of the closest to commercialisation.…
5 crucial things to look for in the annual report of an ASX company that may give you an advantage over other investors
5 crucial things to look out for in the annual report of an ASX company! The ASX reporting season is…
Humm Group (ASX:HUM): Its no Big 4 Bank, but has defied the market in 2024
Humm Group (ASX:HUM) has not had the year you might expect to a financier that is not either a Big…
Here are 5 ASX stocks at 12 month highs, and whether it is time to buy
Here are 5 ASX stocks at 12 month highs! Humm Group (ASX:HUM) Humm has been through a difficult few…
Percheron Therapeutics (ASX:PER): Releasing Phase II data by the end of CY24, and successful data could lead to a major re-rate
It has been less then a year since Antisense Therapeutics changed its name to Percheron Therapeutics (ASX:PER). It is common…
Underlying v Statutory results? There’s a big difference between the 2 – here’s how to tell
When companies report results, you’ll hear underlying and statutory results. What is the difference between the two and how big…
Should I buy Woolworths or Coles shares in FY25?
Should I buy Woolworths or Coles shares? This is one of the top debates Australian investors can have. Obviously, this…
Qantas’ capex bill: The company is coping with a $12bn+ bullet for now, but will it eventually bite shareholders?
Qantas‘ capex needs are bubbling under the surface, but have not gone away. Former CEO Alan Joyce’s tenure came to…
Here are 5 key takeaways from the FY24 results of BHP that you may’ve missed
5 key takeaways from the FY24 results of BHP 1. Copper will be where ‘it is at’ from hereon…
Inghams (ASX:ING): Why the sudden volatility in the last 12 months?
It has been a volatile year on the ASX and poultry company Inghams (ASX:ING) has not been an exception. Between…
Should you buy Nvidia shares in Australia?
Many investors are likely wondering if they should buy Nvidia shares in Australia? Others still might be wondering just who…
Why do ASX REITs trade at a discount to NTA and is it a good or bad sign?
So, your ASX REIT is trading at a ‘discount to NTA’ (Net Tangible Assets). What does this mean – is…
Here’s why Kogan (ASX:KGN) should be on your watchlist for FY25
Kogan shares (ASX:KGN) have been volatile in the past couple of years, but is a better future ahead of it? At…
Proteomics International Laboratories (ASX:PIQ): It thinks its got a great DKD detection test, but do regulators agree?
Proteomics International Laboratories (ASX:PIQ) is one of the larger companies that will be presenting at next month’s Life Sciences Conference.…
What is depreciation? And why is it such an important thing for investors to watch?
Whenever companies report earnings before depreciation, interest, taxes and amortisation (EBITDA), many investors may be wondering what is depreciation? And…
Cyclopharm (ASX:CYC): Meet the latest ASX health stock making money from the USA!
Cyclopharm (ASX:CYC) is a rare species – an ASX stock that has just cracked the US market, but where the…
Aussie Broadband (ASX:ABB): A likeable telco that can reach for the skies again
Aussie Broadband (ASX:ABB) is a good illustration of a Telco stock you can like (as opposed to Telstra). Since listing on…
6 ASX stocks you forgot were listed
Here are 6 ASX stocks you forgot were listed Brisbane Broncos (ASX:BBL) No it is not a mistake. This…
Infomedia (ASX:IFM) is set to rebound strongly in CY24 with the worst of the Tech Wreck behind us
Infomedia (ASX:IFM) is one tech stock that was unfairly sold off during the tech-wreck, but is gradually rebounding with a…
Atlassian (NDQ:TEAM): Why is this Aussie home grown tech company missing the Tech Rebound?
Are Aussie investors really poorer for not having Atlassian (NDQ:TEAM) on the ASX? While many of the ASX’s tech stocks…
Here are 5 Monkeypox stocks to consider as the fight against the epidemic continues
Monkeypox stocks have enjoyed a good run in the last few weeks, with the World Health Organisation (WHO) classifying Monkeypox…
Just when it appeared time to buy A2 Milk (ASX:A2M) again, investors have fresh concerns
A2 Milk shares have been listed on the ASX for over 9 years, listing in late March 2015 at $2.30…
Here are 6 important milestones of ASX biotech companies other than clinical trial results and regulatory approval
The list of major milestones of ASX biotech companies is headed with clinical trial results, regulatory approval and commercialisation. However,…
Recce Pharmaceuticals investors are excited despite the market volatility – and there’s good reason
Recce Pharmaceuticals investors are amongst the few investors in ASX stocks that have a reason to smile right now. Their…
An Investors’ Guide to Critical Minerals: What are they, why are they critical & how to invest in them?
Critical Minerals is the buzzword of the decade in the commodities sector. They’re not just any minerals, they are minerals…
Retail Food Group (ASX:RFG): The most underrated ASX fast food stock might be about to boost its profile
Retail Food Group (ASX:RFG) is flying under many investors’ radars, and we think it is simply because its share price…
Reliance Worldwide (ASX:RWC): Plumbing supplies as a 4-decade high inflation hedge
Reliance Worldwide (ASX:RWC) is one of the best companies to hold amidst record-high inflation, in our view. As a plumbing supplies…
Here are 5 ASX stocks with fluctuating fortunes that have been firmly manifest this reporting season
Here are 5 ASX stocks with fluctuating fortunes (as observed this reporting season) Baby Bunting (ASX:BBN) Baby Bunting has…
4 reasons why Pro Medicus (ASX:PME) just keeps rising to new heights
Another reporting season, another impressive result from Pro Medicus (ASX:PME). Eerily similar to the debate going on about CBA (ASX:CBA),…